Schedule 13G ownership disclosure
Zosano Pharma Corp
Security class unavailable · CUSIP: 98979H103
Event date: 2017-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,083,100
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-17-000320
- Form type
- SC 13G
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Mar 29, 2017
- Reporting period
- Mar 28, 2017
- Description
- Schedule 13G beneficial ownership